世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

HIV/AIDS免疫測定診断市場:製品別(分析装置、キット、試薬)、技術別{酵素結合免疫吸着測定法[ELISA]、化学発光免疫測定法[CLIA]、その他[免疫蛍光測定法(IFA)、放射免疫測定法(RIA)、酵素結合発光測定法(ELFA)]}、エンドユーザ別(病院、診断研究所、血液バンク、その他) 2019-2027年-世界の産業分析、規模、シェア、成長、動向、予測

HIV/AIDS Immunoassay Diagnostics Market (Product: Analyzers and Kits & Reagents; Technology: Enzyme-linked Immunosorbent Assay [ELISA], Chemiluminescence Immunoassay [CLIA], and Others [Immunofluorescent Assay {IFA}, Radioimmunoassay {RIA}, and Enzyme-linked Fluorescent Assay {ELFA}]; and End User: Hospitals, Diagnostic Laboratories, Blood Banks, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

 

出版社 出版年月電子版価格 ページ数
Transparency Market Research
トランスペアレンシーマーケットリサーチ
2019年12月US$5,795
シングルユーザライセンス
175

サマリー

この調査レポートはHIV/AIDS免疫測定診断市場を分析・予測したTransparency Market Researchの市場調査報告書です。

Overview

Global HIV/AIDS Immunoassay Diagnostics Market - Scope of the Report

TMR’s report on the global HIV/AIDS immunoassay diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of same indicators for the said market during the forecast period of 2019 to 2027. The report provides the overall market revenue of the global HIV/AIDS immunoassay diagnostics market for the period of 2017?2027, where 2018 is the base year and 2027 is the forecast year. The report also provides the compound annual growth rate (CAGR) for the global HIV/AIDS immunoassay diagnostics market for the forecast period.

The report has been prepared after an extensive research. Primary research involves bulk of research efforts, wherein, analysts have carried out interviews with industry leaders and opinion makers. Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, articles, journals, and relevant documents to understand the global HIV/AIDS immunoassay diagnostics market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a bottom-up approach to study various phenomena in the global HIV/AIDS immunoassay diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global HIV/AIDS immunoassay diagnostics market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global HIV/AIDS immunoassay diagnostics market. The next section of the global HIV/AIDS immunoassay diagnostics report highlights the USPs, which include key industry developments, technological advancements, epidemiology analysis, immunoassay diagnostic tests for HIV/AIDS, and pricing analysis in the global HIV/AIDS immunoassay diagnostics market.

The report delves into the competition landscape of the global HIV/AIDS immunoassay diagnostics market. Key players operating in the global HIV/AIDS immunoassay diagnostics market have been identified and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global HIV/AIDS immunoassay diagnostics market profiled in this report.

Key Questions Answered in HIV/AIDS Immunoassay Diagnostics Market Report

What are the major drivers, restraints, and opportunities in the global HIV/AIDS immunoassay diagnostics market?
What will be the revenue share projections of key segments in the global HIV/AIDS immunoassay diagnostics market during the forecast period?
Which segment is likely to lead the global HIV/AIDS immunoassay diagnostics market in terms of revenue by 2027?
How mergers & acquisitions among players are widening the scope for the global HIV/AIDS immunoassay diagnostics market?
Which are the leading companies in the global HIV/AIDS immunoassay diagnostics market?
Global HIV/AIDS Immunoassay Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global HIV/AIDS immunoassay diagnostics market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides a detailed explanation of the objectives behind this study and health care compliances laid down by accredited agencies in the purview of the research in the global HIV/AIDS immunoassay diagnostics market. It is followed by market introduction, market dynamics, and an overview of the global HIV/AIDS immunoassay diagnostics market, which include TMR analysis of market drivers, restraints, and trends affecting the growth of the global HIV/AIDS immunoassay diagnostics market. Furthermore, to understand the Y-o-Y trends of the HIV/AIDS immunoassay diagnostics market, a Y-o-Y analysis with elaborated insights on the same has been provided. The next section of the global HIV/AIDS immunoassay diagnostics report highlights the USPs, which include HIV/AIDS immunoassay diagnostics: key industry developments, technological advancements, epidemiology analysis, immunoassay diagnostic tests for HIV/AIDS, and pricing analysis.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global HIV/AIDS immunoassay diagnostics market in terms of product, technology, end user, and region. Key segments under each criteria have been studied at length, and the market share for each of them at the end of 2027 has been provided herein. Such valuable insights enable market stakeholders in making informed business decisions for investments in the global HIV/AIDS immunoassay diagnostics market.



目次

Table of Contents

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global HIV/AIDS Immunoassay Diagnostics Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast, 2017-2027

4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

5.1. Technological Advancements

5.2. Key Industry Developments

5.3. Epidemiology Analysis

5.4. Number of HIV/AIDS Immunoassay Diagnostics Tests, by Region

5.5. Pricing Analysis

6. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Product

6.1. Introduction & Definition

6.2. Global HIV/AIDS Immunoassay Diagnostics Market Value Forecast, by Product, 2017-2027

6.2.1. Analyzers

6.2.2. Kits & Reagents

6.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Product

7. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Technology

7.1. Introduction

7.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

7.2.1. ELISA

7.2.2. CLIA

7.2.3. Others

7.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Technology

8. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by End User

8.1. Introduction

8.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

8.2.1. Hospitals

8.2.2. Diagnostic Laboratories

8.2.3. Blood Banks

8.2.4. Others

8.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by End User

9. Global HIV/AIDS Immunoassay Diagnostics Market Value and Forecast, by Region

9.1. Introduction

9.2. Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2027

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global HIV/AIDS Immunoassay Diagnostics Market Attractiveness, by Region

10. North America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

10.1. Introduction

10.2. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

10.2.1. Analyzers

10.2.2. Kits & Reagents

10.3. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

10.3.1. ELISA

10.3.2. CLIA

10.3.3. Others

10.4. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

10.4.1. Hospitals

10.4.2. Diagnostic Laboratories

10.4.3. Blood Banks

10.4.4. Others

10.5. North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Technology

10.6.3. By End User

10.6.4. By Country

11. Europe HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

11.1. Introduction

11.2. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

11.2.1. Analyzers

11.2.2. Kits & Reagents

11.3. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

11.3.1. ELISA

11.3.2. CLIA

11.3.3. Others

11.4. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

11.4.1. Hospitals

11.4.2. Diagnostic Laboratories

11.4.3. Blood Banks

11.4.4. Others

11.5. Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Russia

11.5.7. Rest of Europe

11.6. Europe HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Technology

11.6.3. By End User

11.6.4. By Country/Sub-region

12. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

12.2.1. Analyzers

12.2.2. Kits & Reagents

12.3. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

12.3.1. ELISA

12.3.2. CLIA

12.3.3. Others

12.4. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

12.4.1. Hospitals

12.4.2. Diagnostic Laboratories

12.4.3. Blood Banks

12.4.4. Others

12.5. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Technology

12.6.3. By End User

12.6.4. By Country/Sub-region

13. Latin America HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

13.1. Introduction

13.2. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

13.2.1. Analyzers

13.2.2. Kits & Reagents

13.3. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

13.3.1. ELISA

13.3.2. CLIA

13.3.3. Others

13.4. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

13.4.1. Hospitals

13.4.2. Diagnostic Laboratories

13.4.3. Blood Banks

13.4.4. Others

13.5. Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Technology

13.6.3. By End User

13.6.4. By Country/Sub-region

14. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

14.2.1. Analyzers

14.2.2. Kits & Reagents

14.3. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

14.3.1. ELISA

14.3.2. CLIA

14.3.3. Others

14.4. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

14.4.1. Hospitals

14.4.2. Diagnostic Laboratories

14.4.3. Blood Banks

14.4.4. Others

14.5. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Technology

14.6.3. By End User

14.6.4. By Country/Sub-region

15. Competition Landscape

15.1. Market Player ? Competition Matrix (By Tier and Size of companies)

15.2. Global HIV/AIDS Immunoassay Diagnostics Market Share Analysis, by Company (2018)

15.3. Company Profiles

15.3.1. F. Hoffmann-La Roche Ltd.

15.3.1.1. Company Description

15.3.1.2. Business Overview

15.3.1.3. Financial Overview

15.3.1.4. Strategic Overview

15.3.1.5. SWOT Analysis

15.3.2. Bio-Rad Laboratories, Inc.

15.3.2.1. Company Description

15.3.2.2. Business Overview

15.3.2.3. Financial Overview

15.3.2.4. Strategic Overview

15.3.2.5. SWOT Analysis

15.3.3. Siemens Healthineers AG.

15.3.3.1. Company Description

15.3.3.2. Business Overview

15.3.3.3. Financial Overview

15.3.3.4. Strategic Overview

15.3.3.5. SWOT Analysis

15.3.4. DiaSorin S.p.A.

15.3.4.1. Company Description

15.3.4.2. Business Overview

15.3.4.3. Financial Overview

15.3.4.4. Strategic Overview

15.3.4.5. SWOT Analysis

15.3.5. Abbott Laboratories

15.3.5.1. Company Description

15.3.5.2. Business Overview

15.3.5.3. Financial Overview

15.3.5.4. Strategic Overview

15.3.5.5. SWOT Analysis

15.3.6. Ortho Clinical Diagnostics (a part of Carlyle Group)

15.3.6.1. Company Description

15.3.6.2. Business Overview

15.3.6.3. Financial Overview

15.3.6.4. Strategic Overview

15.3.6.5. SWOT Analysis

15.3.7. Shenzhen New Industries Biomedical Engineering Co., Ltd.

15.3.7.1. Company Description

15.3.7.2. Business Overview

15.3.7.3. Financial Overview

15.3.7.4. Strategic Overview

15.3.7.5. SWOT Analysis

15.3.8. bioMerieux SA

15.3.8.1. Company Description

15.3.8.2. Business Overview

15.3.8.3. Financial Overview

15.3.8.4. Strategic Overview

15.3.8.5. SWOT Analysis

15.3.9. Fujirebio (Miraca Group)

15.3.9.1. Company Description

15.3.9.2. Business Overview

15.3.9.3. Financial Overview

15.3.9.4. Strategic Overview

15.3.9.5. SWOT Analysis

List of Tables

List of Tables

Table 01: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 02: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 03: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

Table 04: Global HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017-2027

Table 05: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017-2027

Table 06: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 07: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 08: North America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

Table 09: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 10: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 11: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 12: Europe HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

Table 13: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 14: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 15: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 16: Asia Pacific HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

Table 17: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 18: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 19: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 20: Latin America HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

Table 21: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

Table 22: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Product, 2017-2027

Table 23: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2017-2027

Table 24: Middle East & Africa HIV/AIDS Immunoassay Diagnostics Market Value (US$ Mn) Forecast, by End User, 2017-2027

List of Figures

List of Figures

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る